Dr Brian Thomas Miller, MD | |
891 W Main St, Suite 500, Dover Foxcroft, ME 04426-1059 | |
(207) 564-4466 | |
(207) 564-4468 |
Full Name | Dr Brian Thomas Miller |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 891 W Main St, Dover Foxcroft, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215155536 | NPI | - | NPPES |
000762201 | Other | ME | MEDICARE PTAN |
P00654555 | Other | ME | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 2007008857 (Missouri) | Secondary |
207Y00000X | Otolaryngology | 017944 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Brian Thomas Miller, MD 897 W Main St, Dover Foxcroft, ME 04426-1029 Ph: (207) 564-4466 | Dr Brian Thomas Miller, MD 891 W Main St, Suite 500, Dover Foxcroft, ME 04426-1059 Ph: (207) 564-4466 |
News Archive
Long the bane of picky eaters everywhere, broccoli's taste is not just a matter of having a cultured palate; some people can easily taste a bitter compound in the vegetable that others have difficulty detecting. Now a team of Penn researchers has helped uncover the evolutionary history of one of the genes responsible for this trait.
A discovery of a rare mutation that affects cholesterol has ignited hopes of a prescription that can help prevent heart attacks. In the meantime, the announcement by Roche could pose more questions about controversial diabetes medicines. Also a federal report warns Americans of using some Internet pharmacies.
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with low survival rates, with newly diagnosed patients surviving a median of 14 months and recurrent patients surviving a median of only 3 to 9 months. New therapeutic targets and biomarkers for prognosis are urgently needed.
Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure.
› Verified 6 days ago